Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2002 Sep;57(9):823–829. doi: 10.1136/thorax.57.9.823

The pulmonary physician in critical care c 9: Non-ventilatory strategies in ARDS

J Cranshaw 1, M Griffiths 1, T Evans 1
PMCID: PMC1746421  PMID: 12200529

Full Text

The Full Text of this article is available as a PDF (106.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel S. J., Finney S. J., Brett S. J., Keogh B. F., Morgan C. J., Evans T. W. Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax. 1998 Apr;53(4):292–294. doi: 10.1136/thx.53.4.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abraham E., Baughman R., Fletcher E., Heard S., Lamberti J., Levy H., Nelson L., Rumbak M., Steingrub J., Taylor J. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. Crit Care Med. 1999 Aug;27(8):1478–1485. doi: 10.1097/00003246-199908000-00013. [DOI] [PubMed] [Google Scholar]
  3. Abraham E., Park Y. C., Covington P., Conrad S. A., Schwartz M. Liposomal prostaglandin E1 in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial. Crit Care Med. 1996 Jan;24(1):10–15. doi: 10.1097/00003246-199601000-00005. [DOI] [PubMed] [Google Scholar]
  4. Amirkhanian J. D., Merritt T. A. Inhibitory effects of oxyradicals on surfactant function: utilizing in vitro Fenton reaction. Lung. 1998;176(1):63–72. doi: 10.1007/pl00007592. [DOI] [PubMed] [Google Scholar]
  5. Anzueto A., Baughman R. P., Guntupalli K. K., Weg J. G., Wiedemann H. P., Raventós A. A., Lemaire F., Long W., Zaccardelli D. S., Pattishall E. N. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med. 1996 May 30;334(22):1417–1421. doi: 10.1056/NEJM199605303342201. [DOI] [PubMed] [Google Scholar]
  6. Beale R. J., Bryg D. J., Bihari D. J. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med. 1999 Dec;27(12):2799–2805. doi: 10.1097/00003246-199912000-00032. [DOI] [PubMed] [Google Scholar]
  7. Beetens J. R., Loots W., Somers Y., Coene M. C., De Clerck F. Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo. Biochem Pharmacol. 1986 Mar 15;35(6):883–891. doi: 10.1016/0006-2952(86)90072-9. [DOI] [PubMed] [Google Scholar]
  8. Bernard G. R., Artigas A., Brigham K. L., Carlet J., Falke K., Hudson L., Lamy M., Legall J. R., Morris A., Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):818–824. doi: 10.1164/ajrccm.149.3.7509706. [DOI] [PubMed] [Google Scholar]
  9. Bernard G. R., Luce J. M., Sprung C. L., Rinaldo J. E., Tate R. M., Sibbald W. J., Kariman K., Higgins S., Bradley R., Metz C. A. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987 Dec 17;317(25):1565–1570. doi: 10.1056/NEJM198712173172504. [DOI] [PubMed] [Google Scholar]
  10. Bernard G. R., Vincent J. L., Laterre P. F., LaRosa S. P., Dhainaut J. F., Lopez-Rodriguez A., Steingrub J. S., Garber G. E., Helterbrand J. D., Ely E. W. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 Mar 8;344(10):699–709. doi: 10.1056/NEJM200103083441001. [DOI] [PubMed] [Google Scholar]
  11. Bernard G. R., Wheeler A. P., Arons M. M., Morris P. E., Paz H. L., Russell J. A., Wright P. E. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest. 1997 Jul;112(1):164–172. doi: 10.1378/chest.112.1.164. [DOI] [PubMed] [Google Scholar]
  12. Bernard G. R., Wheeler A. P., Russell J. A., Schein R., Summer W. R., Steinberg K. P., Fulkerson W. J., Wright P. E., Christman B. W., Dupont W. D. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med. 1997 Mar 27;336(13):912–918. doi: 10.1056/NEJM199703273361303. [DOI] [PubMed] [Google Scholar]
  13. Biffl W. L., Moore F. A., Moore E. E., Haenel J. B., McIntyre R. C., Jr, Burch J. M. Are corticosteroids salvage therapy for refractory acute respiratory distress syndrome? Am J Surg. 1995 Dec;170(6):591–596. doi: 10.1016/s0002-9610(99)80022-1. [DOI] [PubMed] [Google Scholar]
  14. Bone R. C., Fisher C. J., Jr, Clemmer T. P., Slotman G. J., Metz C. A., Balk R. A. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987 Sep 10;317(11):653–658. doi: 10.1056/NEJM198709103171101. [DOI] [PubMed] [Google Scholar]
  15. Bone R. C., Slotman G., Maunder R., Silverman H., Hyers T. M., Kerstein M. D., Ursprung J. J. Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group. Chest. 1989 Jul;96(1):114–119. doi: 10.1378/chest.96.1.114. [DOI] [PubMed] [Google Scholar]
  16. Brun-Buisson C., Brochard L. Corticosteroid therapy in acute respiratory distress syndrome: better late than never? JAMA. 1998 Jul 8;280(2):182–183. doi: 10.1001/jama.280.2.182. [DOI] [PubMed] [Google Scholar]
  17. Chabot F., Mitchell J. A., Gutteridge J. M., Evans T. W. Reactive oxygen species in acute lung injury. Eur Respir J. 1998 Mar;11(3):745–757. [PubMed] [Google Scholar]
  18. Chang D. W., DeSanti L., Demling R. H. Anticatabolic and anabolic strategies in critical illness: a review of current treatment modalities. Shock. 1998 Sep;10(3):155–160. doi: 10.1097/00024382-199809000-00001. [DOI] [PubMed] [Google Scholar]
  19. Cohen J., Carlet J. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med. 1996 Sep;24(9):1431–1440. doi: 10.1097/00003246-199609000-00002. [DOI] [PubMed] [Google Scholar]
  20. Cuthbertson B. H., Dellinger P., Dyar O. J., Evans T. E., Higenbottam T., Latimer R., Payen D., Stott S. A., Webster N. R., Young J. D. UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS. Intensive Care Med. 1997 Dec;23(12):1212–1218. doi: 10.1007/s001340050488. [DOI] [PubMed] [Google Scholar]
  21. Davey-Quinn A., Gedney J. A., Whiteley S. M., Bellamy M. C. Extravascular lung water and acute respiratory distress syndrome--oxygenation and outcome. Anaesth Intensive Care. 1999 Aug;27(4):357–362. doi: 10.1177/0310057X9902700404. [DOI] [PubMed] [Google Scholar]
  22. Dellinger R. P., Zimmerman J. L., Taylor R. W., Straube R. C., Hauser D. L., Criner G. J., Davis K., Jr, Hyers T. M., Papadakos P. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med. 1998 Jan;26(1):15–23. doi: 10.1097/00003246-199801000-00011. [DOI] [PubMed] [Google Scholar]
  23. Domenighetti G., Suter P. M., Schaller M. D., Ritz R., Perret C. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study. J Crit Care. 1997 Dec;12(4):177–182. doi: 10.1016/s0883-9441(97)90029-0. [DOI] [PubMed] [Google Scholar]
  24. Elsayed-Ali HE, Norris TB, Pessot MA, Mourou GA. Time-resolved observation of electron-phonon relaxation in copper. Phys Rev Lett. 1987 Mar 23;58(12):1212–1215. doi: 10.1103/PhysRevLett.58.1212. [DOI] [PubMed] [Google Scholar]
  25. Fein A. M., Calalang-Colucci M. G. Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock. Crit Care Clin. 2000 Apr;16(2):289–317. doi: 10.1016/s0749-0704(05)70111-1. [DOI] [PubMed] [Google Scholar]
  26. Gadek J. E., DeMichele S. J., Karlstad M. D., Pacht E. R., Donahoe M., Albertson T. E., Van Hoozen C., Wennberg A. K., Nelson J. L., Noursalehi M. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med. 1999 Aug;27(8):1409–1420. doi: 10.1097/00003246-199908000-00001. [DOI] [PubMed] [Google Scholar]
  27. Gallart L., Lu Q., Puybasset L., Umamaheswara Rao G. S., Coriat P., Rouby J. J. Intravenous almitrine combined with inhaled nitric oxide for acute respiratory distress syndrome. The NO Almitrine Study Group. Am J Respir Crit Care Med. 1998 Dec;158(6):1770–1777. doi: 10.1164/ajrccm.158.6.9804066. [DOI] [PubMed] [Google Scholar]
  28. Gerlach H., Rossaint R., Pappert D., Falke K. J. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest. 1993 Aug;23(8):499–502. doi: 10.1111/j.1365-2362.1993.tb00797.x. [DOI] [PubMed] [Google Scholar]
  29. Gregory T. J., Steinberg K. P., Spragg R., Gadek J. E., Hyers T. M., Longmore W. J., Moxley M. A., Cai G. Z., Hite R. D., Smith R. M. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997 Apr;155(4):1309–1315. doi: 10.1164/ajrccm.155.4.9105072. [DOI] [PubMed] [Google Scholar]
  30. Hechtman H. B., Valeri C. R., Shepro D. Role of humoral mediators in adult respiratory distress syndrome. Chest. 1984 Oct;86(4):623–627. doi: 10.1378/chest.86.4.623. [DOI] [PubMed] [Google Scholar]
  31. Holcroft J. W., Vassar M. J., Weber C. J. Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. A prospective trial. Ann Surg. 1986 Apr;203(4):371–378. doi: 10.1097/00000658-198604000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hooper R. G., Kearl R. A. Established ARDS treated with a sustained course of adrenocortical steroids. Chest. 1990 Jan;97(1):138–143. doi: 10.1378/chest.97.1.138. [DOI] [PubMed] [Google Scholar]
  33. Humphrey H., Hall J., Sznajder I., Silverstein M., Wood L. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest. 1990 May;97(5):1176–1180. doi: 10.1378/chest.97.5.1176. [DOI] [PubMed] [Google Scholar]
  34. Jepsen S., Herlevsen P., Knudsen P., Bud M. I., Klausen N. O. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study. Crit Care Med. 1992 Jul;20(7):918–923. doi: 10.1097/00003246-199207000-00004. [DOI] [PubMed] [Google Scholar]
  35. Kaminski N., Allard J. D., Pittet J. F., Zuo F., Griffiths M. J., Morris D., Huang X., Sheppard D., Heller R. A. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1778–1783. doi: 10.1073/pnas.97.4.1778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. King B. K., Kudsk K. A., Li J., Wu Y., Renegar K. B. Route and type of nutrition influence mucosal immunity to bacterial pneumonia. Ann Surg. 1999 Feb;229(2):272–278. doi: 10.1097/00000658-199902000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Leff J. A., Baer J. W., Kirkman J. M., Bodman M. E., Shanley P. F., Cho O. J., Ostro M. J., Repine J. E. Liposome-entrapped PGE1 posttreatment decreases IL-1 alpha-induced neutrophil accumulation and lung leak in rats. J Appl Physiol (1985) 1994 Jan;76(1):151–157. doi: 10.1152/jappl.1994.76.1.151. [DOI] [PubMed] [Google Scholar]
  38. Lucas C. E., Ledgerwood A. M. Pulmonary response of massive steroids in seriously injured patients. Ann Surg. 1981 Sep;194(3):256–261. doi: 10.1097/00000658-198109000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Luce J. M., Montgomery A. B., Marks J. D., Turner J., Metz C. A., Murray J. F. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis. 1988 Jul;138(1):62–68. doi: 10.1164/ajrccm/138.1.62. [DOI] [PubMed] [Google Scholar]
  40. Lundin S., Mang H., Smithies M., Stenqvist O., Frostell C. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med. 1999 Sep;25(9):911–919. doi: 10.1007/s001340050982. [DOI] [PubMed] [Google Scholar]
  41. Manalo E., Merritt T. A., Kheiter A., Amirkhanian J., Cochrane C. Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4. Pediatr Res. 1996 Jun;39(6):947–952. doi: 10.1203/00006450-199606000-00004. [DOI] [PubMed] [Google Scholar]
  42. McCloskey R. V., Straube R. C., Sanders C., Smith S. M., Smith C. R. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med. 1994 Jul 1;121(1):1–5. doi: 10.7326/0003-4819-121-1-199407010-00001. [DOI] [PubMed] [Google Scholar]
  43. Meduri G. U., Belenchia J. M., Estes R. J., Wunderink R. G., el Torky M., Leeper K. V., Jr Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest. 1991 Oct;100(4):943–952. doi: 10.1378/chest.100.4.943. [DOI] [PubMed] [Google Scholar]
  44. Meduri G. U., Chinn A. J., Leeper K. V., Wunderink R. G., Tolley E., Winer-Muram H. T., Khare V., Eltorky M. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest. 1994 May;105(5):1516–1527. doi: 10.1378/chest.105.5.1516. [DOI] [PubMed] [Google Scholar]
  45. Meduri G. U., Headley A. S., Golden E., Carson S. J., Umberger R. A., Kelso T., Tolley E. A. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998 Jul 8;280(2):159–165. doi: 10.1001/jama.280.2.159. [DOI] [PubMed] [Google Scholar]
  46. Meduri G. U., Headley S., Tolley E., Shelby M., Stentz F., Postlethwaite A. Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest. 1995 Nov;108(5):1315–1325. doi: 10.1378/chest.108.5.1315. [DOI] [PubMed] [Google Scholar]
  47. Meyer J., Theilmeier G., Van Aken H., Bone H. G., Busse H., Waurick R., Hinder F., Booke M. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure. Anesth Analg. 1998 Apr;86(4):753–758. doi: 10.1097/00000539-199804000-00015. [DOI] [PubMed] [Google Scholar]
  48. Michael J. R., Barton R. G., Saffle J. R., Mone M., Markewitz B. A., Hillier K., Elstad M. R., Campbell E. J., Troyer B. E., Whatley R. E. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1372–1380. doi: 10.1164/ajrccm.157.5.96-10089. [DOI] [PubMed] [Google Scholar]
  49. Mitchell J. P., Schuller D., Calandrino F. S., Schuster D. P. Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis. 1992 May;145(5):990–998. doi: 10.1164/ajrccm/145.5.990. [DOI] [PubMed] [Google Scholar]
  50. Murakami S., Bacha E. A., Mazmanian G. M., Détruit H., Chapelier A., Dartevelle P., Hervé P. Effects of various timings and concentrations of inhaled nitric oxide in lung ischemia-reperfusion. The Paris-Sud University Lung Transplantation Group. Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):454–458. doi: 10.1164/ajrccm.156.2.9608007. [DOI] [PubMed] [Google Scholar]
  51. Ortolani O., Conti A., De Gaudio A. R., Masoni M., Novelli G. Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome. Shock. 2000 Jan;13(1):14–18. doi: 10.1097/00024382-200013010-00003. [DOI] [PubMed] [Google Scholar]
  52. Pacht E. R., Timerman A. P., Lykens M. G., Merola A. J. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest. 1991 Nov;100(5):1397–1403. doi: 10.1378/chest.100.5.1397. [DOI] [PubMed] [Google Scholar]
  53. Payen D. M. Inhaled nitric oxide and acute lung injury. Clin Chest Med. 2000 Sep;21(3):519-29, ix. doi: 10.1016/s0272-5231(05)70163-5. [DOI] [PubMed] [Google Scholar]
  54. Petrak R. A., Balk R. A., Bone R. C. Prostaglandins, cyclo-oxygenase inhibitors, and thromboxane synthetase inhibitors in the pathogenesis of multiple systems organ failure. Crit Care Clin. 1989 Apr;5(2):303–314. [PubMed] [Google Scholar]
  55. Pittet J. F., Mackersie R. C., Martin T. R., Matthay M. A. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med. 1997 Apr;155(4):1187–1205. doi: 10.1164/ajrccm.155.4.9105054. [DOI] [PubMed] [Google Scholar]
  56. Reyes A., Roca J., Rodriguez-Roisin R., Torres A., Ussetti P., Wagner P. D. Effect of almitrine on ventilation-perfusion distribution in adult respiratory distress syndrome. Am Rev Respir Dis. 1988 May;137(5):1062–1067. doi: 10.1164/ajrccm/137.5.1062. [DOI] [PubMed] [Google Scholar]
  57. Rossaint R., Falke K. J., López F., Slama K., Pison U., Zapol W. M. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993 Feb 11;328(6):399–405. doi: 10.1056/NEJM199302113280605. [DOI] [PubMed] [Google Scholar]
  58. Rossaint R., Slama K., Steudel W., Gerlach H., Pappert D., Veit S., Falke K. Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome. Intensive Care Med. 1995 Mar;21(3):197–203. doi: 10.1007/BF01701472. [DOI] [PubMed] [Google Scholar]
  59. Schuller D., Mitchell J. P., Calandrino F. S., Schuster D. P. Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome? Chest. 1991 Oct;100(4):1068–1075. doi: 10.1378/chest.100.4.1068. [DOI] [PubMed] [Google Scholar]
  60. Silverman H. J., Slotman G., Bone R. C., Maunder R., Hyers T. M., Kerstein M. D., Ursprung J. J. Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Results from the prostaglandin E1 multicenter trial. The Prostaglandin E1 Study Group. Chest. 1990 Aug;98(2):405–410. doi: 10.1378/chest.98.2.405. [DOI] [PubMed] [Google Scholar]
  61. Sinuff T., Cook D. J., Peterson J. C., Fuller H. D. Development, implementation, and evaluation of a ketoconazole practice guideline for ARDS prophylaxis. J Crit Care. 1999 Mar;14(1):1–6. doi: 10.1016/s0883-9441(99)90001-1. [DOI] [PubMed] [Google Scholar]
  62. Sladen A. Methylprednisolone. Pharmacologic doses in shock lung syndrome. J Thorac Cardiovasc Surg. 1976 May;71(5):800–806. [PubMed] [Google Scholar]
  63. Slotman G. J., Burchard K. W., D'Arezzo A., Gann D. S. Ketoconazole prevents acute respiratory failure in critically ill surgical patients. J Trauma. 1988 May;28(5):648–654. doi: 10.1097/00005373-198805000-00015. [DOI] [PubMed] [Google Scholar]
  64. Troncy E., Collet J. P., Shapiro S., Guimond J. G., Blair L., Ducruet T., Francoeur M., Charbonneau M., Blaise G. Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1483–1488. doi: 10.1164/ajrccm.157.5.9707090. [DOI] [PubMed] [Google Scholar]
  65. Walmrath D., Schneider T., Schermuly R., Olschewski H., Grimminger F., Seeger W. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996 Mar;153(3):991–996. doi: 10.1164/ajrccm.153.3.8630585. [DOI] [PubMed] [Google Scholar]
  66. Weigelt J. A., Norcross J. F., Borman K. R., Snyder W. H., 3rd Early steroid therapy for respiratory failure. Arch Surg. 1985 May;120(5):536–540. doi: 10.1001/archsurg.1985.01390290018003. [DOI] [PubMed] [Google Scholar]
  67. Wiswell T. E., Smith R. M., Katz L. B., Mastroianni L., Wong D. Y., Willms D., Heard S., Wilson M., Hite R. D., Anzueto A. Bronchopulmonary segmental lavage with Surfaxin (KL(4)-surfactant) for acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999 Oct;160(4):1188–1195. doi: 10.1164/ajrccm.160.4.9808118. [DOI] [PubMed] [Google Scholar]
  68. Yu M., Tomasa G. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med. 1993 Nov;21(11):1635–1642. doi: 10.1097/00003246-199311000-00010. [DOI] [PubMed] [Google Scholar]
  69. Zaloga G. P. Dietary lipids: ancestral ligands and regulators of cell signaling pathways. Crit Care Med. 1999 Aug;27(8):1646–1648. doi: 10.1097/00003246-199908000-00047. [DOI] [PubMed] [Google Scholar]
  70. Ziegler E. J., Fisher C. J., Jr, Sprung C. L., Straube R. C., Sadoff J. C., Foulke G. E., Wortel C. H., Fink M. P., Dellinger R. P., Teng N. N. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med. 1991 Feb 14;324(7):429–436. doi: 10.1056/NEJM199102143240701. [DOI] [PubMed] [Google Scholar]
  71. Zwissler B., Kemming G., Habler O., Kleen M., Merkel M., Haller M., Briegel J., Welte M., Peter K. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1671–1677. doi: 10.1164/ajrccm.154.6.8970353. [DOI] [PubMed] [Google Scholar]
  72. al-Saady N. M., Blackmore C. M., Bennett E. D. High fat, low carbohydrate, enteral feeding lowers PaCO2 and reduces the period of ventilation in artificially ventilated patients. Intensive Care Med. 1989;15(5):290–295. doi: 10.1007/BF00263863. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES